Boston // I can't help but wonder how think the CFO's departure strengthens "to the buyout narrative." In the case of Amedica it does not and unless you are privy to confidential information, continually touting a buyout is coming is irresponsible. There is nothing positive about Ty's departure.
By the way, how did your FDA FOIA request work out, are you going to share your findings with all those you tell a buyout is coming?
News 
Market Data 
Discover 
